Cell & Gene: The Podcast

Erin Harris

Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.

About PodLP

PodLP is the leading podcast app for feature phones. With 10M+ installs in nearly every country, PodLP is available for KaiOS on the KaiStore and JioStore, as well as Cloud Phone. If you're interested in promoting "Cell & Gene: The Podcast" on PodLP, contact sales@podlp.com.

Screenshots are mockup renders of PodLP for KaiOS. Actual design may vary based on platform, operating system, and app version.

Cell & Gene: The Podcast

Episodes (128)

Thursday Inside a Breakthrough HER2 Immunotherapy for PMO with OS Therapies’ Paul Romness
Jan 29th Building Safer CRISPR Medicines for CVD with Scribe Therapeutics' Benjamin Oakes
Jan 15th Advancing Off-the-Shelf CRISPR CAR-T Therapies into the Community Setting with Caribou Biosciences' Rachel Haurwitz

Cell & Gene: The Podcast

Feb 12, 2026
14¼ minutes
10 MB

We love to hear from our listeners. Send us a message. In episode 122 of Cell & Gene: The Podcast, Host Erin Harris talks to Paul Romness, CEO of OS Therapies, to learn the company’s mission to address the severe unmet need in pulmonary metastatic osteosarcoma (PMO), a rare pediatric cancer with no established standard of care once it metastasizes. Romness explains how OS Therapies’ off-the-shelf HER2-targeted immunotherapy aims to significantly improve outcomes by stimulating a robust immune response with minimal side effects. He highlights results from a multicenter Phase 2B trial showing markedly improved overall survival rate...

Cell & Gene: The Podcast

Inside a Breakthrough HER2 Immunotherapy for PMO with OS Therapies’ Paul Romness

Erin Harris

00:00 -14:20